Suppression of Colon Tumorigenesis in Mutant <i>Apc</i> Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-CateninKevin J. Lee, Gary A. Piazza, Wen‐Chi Chang et al.|Cancer Prevention Research|2021Cited by 19
Abstract A30: Novel non-COX inhibitory sulindac derivative with PDE10 inhibitory activity reduces incidence and multiplicity of colorectal adenomas in the APC+/min-FCCC mouse modelKevin J. Lee, Wen‐Chi Chang, Xi Chen et al.|Cancer Research|2017Cited by 1
Abstract 5174: Phosphodiesterase 10A inhibition as a novel approach to suppress β-catenin signaling in ovarian cancer cellsLuciana Madeira da Silva, Gary A. Piazza, Elaine Gavin et al.|Cancer Research|2017Cited by 1
Abstract 1140: Characterization of a novel PDE10 inhibitor in lung tumor cells and an orthotopic mouse model of lung cancerVerónica Ramírez‐Alcántara, Gary A. Piazza, Kevin J. Lee et al.|Cancer Research|2017Cited by 1
Abstract 331: Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKGKevin J. Lee, Gary A. Piazza, Ashley S. Lindsey et al.|Cancer Research|2016Cited by 1